Category: GlaxoSmithKline (GSK)
-
Pfizer, BioNTech hit back against GSK mRNA suits in UPC, Ireland: file UK revocation actionÂ
The move does not come as a major surprise, given the pharma companies’ previous success against GlaxoSmithKline in the UK.
-
BREAKING: GSK cashes in on license deal as CureVac settles U.S. patent dispute with acquirer BioNTech and Pfizer for $790M+
Pfizer and BioNTech have settled their three-year COVID vaccine-related patent infringement dispute with CureVac in the U.S., granting the latter and its licensing partner GSK $370 million each.